Skip to content
Open access

Coexistence of immunophenotypically normal and aberrant mast cells in patients with clonal mast cell diseases associates with more indolent subtypes and less severe disease characteristics.

Sep 2026 · Cytometry. Part B, Clinical cytometry · 0 citations · 36 references
Medicine

TL;DR

Assessing the coexistence of normal and pathologic MCs is a widely available, fast, and sensitive diagnostic and prognostic tool and may also be used in SM disease follow-up and treatment monitoring.

Abstract

Aberrant antigen expression on mast cells (MCs) is one of the most accurate diagnostic markers for clonal MC diseases (CMCD). Although the coexistence of normal and pathologic MCs is frequently seen, the disease characteristics associated with it have been minimally investigated. We aimed to gain further insight into the relevance of partial aberrancy for establishing the diagnosis and risk stratification of systemic mastocytosis (SM) and monoclonal MC activation syndromes (MMAS). In patients with MMAS or SM, MC load, KIT D816V variant allele fraction (VAF), immunophenotype, mutational profile, basal serum tryptase (BST), and hematology parameters were evaluated to characterize the coexistence of normal and aberrant MCs. From 207 patients with CMCD, 75% of patients with MMAS, 67% with non-advanced SM (non-AdvSM), and 27% with advanced SM (AdvSM) exhibited partial aberrancy. This turned out to be one of the most discriminative parameters between indolent and advanced subtypes. Partial aberrancy was associated with less severe disease characteristics, that is, more indolent subtype, lower MC burden, KIT D816V VAF and BST, a mature MC immunophenotype, hematological parameters more closely corresponding to the normal-range values, and in a subgroup of patients with an SM-AHN, a less complex mutational profile. Assessing the coexistence of normal and pathologic MCs is a widely available, fast, and sensitive diagnostic and prognostic tool and may also be used in SM disease follow-up and treatment monitoring.

Read PDF

Similar papers

Open access Sep 2026

The Clinical and Molecular Characteristics of Systemic Mastocytosis with Associated Non-Mast Cell Myeloid Neoplasm

Background: Systemic mastocytosis (SM) with associated non-mast cell myeloid neoplasm is a rare condition, defined by the presence of both SM and a clonal non-mast cell neoplasm. Due to its rarity, the demographic and molecular characteristics are poorly understood. This study investigated seven patients diagnosed with...

Neha Seth, Pratik Q. Deb · 0 citations
Sep 2026

Characterization of morphological and immunophenotypic heterogeneity in adult T-cell leukemia/lymphoma and development of a peripheral blood tumor load-based prognostic index.

We evaluated morphologic and immunophenotypic features of adult T-cell leukemia/lymphoma (ATLL) using morphology and flow cytometry (FCM), compared tumor cell proportions in bone marrow (BM) and peripheral blood (PB), and assessed whether these parameters could improve prognostication beyond existing indices for aggres...

Feng Zhang, Hua-Rong Zhou, Fei Gao et al. · 0 citations
Review Open access Oct 2026

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms

Plasma cell neoplasms (PCNs) are a group of malignant neoplasms originating from the monoclonal expansion of immunoglobulin-secreting, terminally differentiated B cells, i.e., plasma cells (PCs). PCNs include monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma (solitary plasmacytoma of the bone and...

Shih-Sung Chuang, C. Chang · 0 citations
Open access 2026

Clonality patterns of IGH and TCRB gene rearrangement across lymphoma and non-lymphoma: a pitfall in the interpretation of multiplex PCR.

Clonality testing using BIOMED-2-based multiplex PCR is widely applied in routine diagnostics, but its interpretation can be complicated by clonal-like peaks arising from non-neoplastic immune responses. In this study, we retrospectively analyzed routine diagnostic cases examined by IGH and TCRB multiplex PCR and asses...

Miwa Fujikawa, T. Miyata-Takata, Akihiro Kitadate et al. · 0 citations
Open access Sep 2026

Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1

It is suggested that LMO2 and FOXP1 expression may provide complementary prognostic information and help identify clinically distinct immunophenotypic subsets in FL.

Tulay Koc, Sedanur Aydın, Zeynep Öztürk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.